コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 expression of NO synthase (NOS) in the human uterine artery.
2 major blood supply to the ovary was from the uterine artery.
3 uterus was through anastomoses with the main uterine artery.
4 at 2 and 6 months after embolization of the uterine arteries.
5 oppler flow velocimetry of the umbilical and uterine arteries.
6 enic tone were reversed by TET2 knockdown in uterine arteries.
7 cts of hypoxia on STOCs and myogenic tone in uterine arteries.
8 nd phenylephrine-induced vasoconstriction of uterine arteries.
9 aneous transient outward currents (STOCs) in uterine arteries.
10 contractile and anti-dilatory effects on rat uterine arteries.
11 pro-contractile and anti-dilatory effects on uterine arteries.
12 a-mediated, pregnancy-induced remodelling of uterine arteries.
13 fects of hypoxia on BKCa channel currents in uterine arteries.
14 and endothelial cells of chorionic villi and uterine arteries.
15 embolization had bilateral ovarian artery-to-uterine artery anastomoses that were classified as high
18 = 8) ewes had flow probes implanted on main uterine arteries and catheters in branches of the uterin
19 d inhibition of the BKCa channel activity in uterine arteries and new insights in understanding and a
20 tal growth parameters and blood flows of the uterine arteries and umbilical cord were normal througho
22 that hypoxia reduced AMPK activation in the uterine artery and placenta, and AICAR increased AMPK ac
28 ient reduction and irregular fluctuations in uterine artery blood flow associated with cardiac arrhyt
29 itude (>2500 m or 8200 ft) residence reduces uterine artery blood flow during pregnancy, contributing
30 ategy for improving fetal growth and raising uterine artery blood flow in pregnancy, which may be imp
31 rivascular adipose tissue (PVAT) potentiates uterine artery blood flow in pregnant rats, although not
32 were surgically instrumented with bilateral uterine artery blood flow transducers, and uterine and f
38 adequate invasion and remodeling of maternal uterine arteries by extravillous trophoblasts (EVTs) in
39 ses pharmacomechanical coupling of the ovine uterine artery by inhibiting the efficiency of receptor-
40 tment improved maternal metabolic health and uterine artery compliance but did not rescue obesity-ind
41 ose intolerance in pregnancy we show reduced uterine artery compliance, placental structural changes
46 educed uterine artery diameter and increased uterine artery contractility in normoxic mice, providing
47 l inhibition of AMPK with Compound C reduced uterine artery diameter and increased uterine artery con
51 erefore, by characterizing pregnancies using uterine artery Doppler RI before dNK cell isolation, we
52 n the first trimester, pregnancies with high uterine artery Doppler RI demonstrate alterations in pla
53 Treatment and close monitoring including uterine artery Doppler scans and timely delivery may imp
58 risk of pre-eclampsia by abnormal two-stage uterine-artery doppler analysis or a previous history of
59 phoblast (EVT) cells to remodel the maternal uterine arteries during the first and second trimesters
61 ications during subsequent pregnancies after uterine artery embolization (UAE) for postpartum hemorrh
63 reintervention (compared with myomectomy or uterine artery embolization [UAE]), but rates of more se
64 o hundred consecutive patients who underwent uterine artery embolization at one institution were pros
65 moral arterial access in patients undergoing uterine artery embolization for the treatment of fibroid
66 ntification of those who would be at risk of uterine artery embolization or ovarian failure, and in t
70 ure fertility; new treatment options include uterine artery embolization via interventional radiologi
72 esponse to medical treatment, myomectomy and uterine-artery embolization are therapeutic options.
73 the myomectomy group and 80.0+/-22.0 in the uterine-artery embolization group (mean adjusted differe
74 hom 105 underwent myomectomy) and 127 to the uterine-artery embolization group (of whom 98 underwent
76 ial to evaluate myomectomy, as compared with uterine-artery embolization, in women who had symptomati
78 ate proliferation of pregnancy-derived ovine uterine artery endothelial cells (P-UAECs) through beta-
79 timulate pregnancy-specific proliferation of uterine artery endothelial cells derived from pregnant (
81 CI 182 780 (0.1-3.0 microg min(-1)) into one uterine artery for 10 min before and 50 min after E2beta
82 ity index) and RI (Doppler calculated in the uterine artery) for both supervised and unsupervised cla
83 presence of PVAT-conditioned media, isolated uterine arteries from both pregnant and non-pregnant rat
86 .19 +/- 0.15 and 6.62 +/- 0.12 (P < 0.05) in uterine arteries from normoxic and chronically hypoxic s
87 .09 +/- 0.11 and 5.51 +/- 0.08 (P < 0.05) in uterine arteries from normoxic and chronically hypoxic s
89 bundance and BKCa channel current density in uterine arteries from pregnant sheep exposed to high-alt
92 m in inhibiting Ca(V)1.2 channel currents in uterine artery haemodynamic adaptation to pregnancy in a
95 th profound structural alterations of murine uterine arteries, including the occurrence of outward hy
96 from control and IUGR (induced by bilateral uterine artery ligation at day 18 of fetal life) animals
98 ysis, we investigated the effect of maternal uterine artery ligation causing uteroplacental insuffici
102 nant Sprague-Dawley dams underwent bilateral uterine artery ligation or anesthesia (control) at e19.5
103 d growth retardation by performing bilateral uterine artery ligation upon pregnant rats 2 days prior
108 T) caused by chronic hypoxia was examined in uterine arteries obtained from normoxic (control) and ch
111 at gestational hypoxia downregulated TET2 in uterine arteries of pregnant sheep and TET2 was a target
113 nts by reducing steady-state inactivation in uterine arteries of pregnant sheep, recapitulating the p
117 y applying silver clips around the aorta and uterine arteries on gestational day 14, resulting in ~ 4
120 he group of patients with prior occlusion of uterine arteries (p = 0.025) without increasing operatin
121 onclude that temporary clamping of bilateral uterine arteries prior to laparoscopic myomectomy is a s
125 ratio < 5(th) centile, or abnormal umbilical/uterine artery pulsatility index; and 2) non-severe IUGR
126 xidant MitoQ in hypoxic pregnancy normalises uterine artery reactivity and prevents vascular remodell
130 and third trimesters were 0.50 and 0.32 for uterine artery resistance index and umbilical artery pul
131 rs and persistence in the highest tertile of uterine artery resistance index from the second trimeste
133 udy, we correlated increased first trimester uterine artery resistance with a biological abnormality
134 ctivator inhibitor (PAI) 1 to PAI-2 and mean uterine-artery resistance index (UtARI)] and placental a
136 -targeted therapy against adverse changes in uterine artery structure and function in high-risk pregn
137 -targeted therapy against adverse changes in uterine artery structure and function in high-risk pregn
140 suppression of Ca(V)1.2 channel activity in uterine arteries to facilitate increased uterine blood f
143 versus VSM ERalpha and ERbeta expression in uterine arteries (UAs) during the ovarian cycle, pregnan
144 ivo vasoreactivity studies were conducted in uterine arteries (UtA) isolated from pregnant mice expos
145 .5, maternal nitrate/nitrite concentrations, uterine artery (UtA) blood flow and endothelial function
146 (PRKAA1) have been implicated in the greater uterine artery (UtA) blood flow and relative protection
147 e hypothesis that adipose tissue surrounding uterine arteries (uterine perivascular adipose tissue; P
148 -targeted antioxidant MitoQ protects against uterine artery vascular dysfunction and remodelling, sup
149 et clinical need for therapeutics that treat uterine artery vascular dysfunction in adverse pregnancy
151 Uterine handling led to an acute increase in uterine artery vascular resistance, fetal peripheral vas
152 mbilical artery vascular resistance, but not uterine artery vascular resistance, was associated with
154 ss and improved glucose tolerance, increased uterine artery volume blood flow, and decreased placenta
155 onse of 5-HT-induced InsP3 generation in the uterine artery was decreased from 251.3 +/- 24.2 pmol (m
156 of total cardiac output flowing through the uterine artery was increased with AICAR in hypoxic mice
157 though 5-HT2A receptor density (Bmax) in the uterine artery was not changed in chronically hypoxic sh
158 nsP3 generated, the contractile force of the uterine artery was significantly less in chronically hyp
164 the production of reactive oxygen species in uterine arteries, which was blocked by N-acetylcysteine.